Cargando…
825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781757/ http://dx.doi.org/10.1093/ofid/ofu052.533 |
| _version_ | 1783295032648794112 |
|---|---|
| author | Raad, Issam Mullane, Kathleen M. Selleslag, Dominik Thompson, George Neofytos, Dionissios Shoham, Shmuel Lee, Misun Maher, Rochelle Zeiher, Bernhardt Marty, Francisco M. |
| author_facet | Raad, Issam Mullane, Kathleen M. Selleslag, Dominik Thompson, George Neofytos, Dionissios Shoham, Shmuel Lee, Misun Maher, Rochelle Zeiher, Bernhardt Marty, Francisco M. |
| author_sort | Raad, Issam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5781757 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57817572018-03-01 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections Raad, Issam Mullane, Kathleen M. Selleslag, Dominik Thompson, George Neofytos, Dionissios Shoham, Shmuel Lee, Misun Maher, Rochelle Zeiher, Bernhardt Marty, Francisco M. Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781757/ http://dx.doi.org/10.1093/ofid/ofu052.533 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Raad, Issam Mullane, Kathleen M. Selleslag, Dominik Thompson, George Neofytos, Dionissios Shoham, Shmuel Lee, Misun Maher, Rochelle Zeiher, Bernhardt Marty, Francisco M. 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections |
| title | 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections |
| title_full | 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections |
| title_fullStr | 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections |
| title_full_unstemmed | 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections |
| title_short | 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections |
| title_sort | 825 a phase 3, randomized, double-blind, non-inferiority trial to evaluate efficacy and safety of isavuconazole vs voriconazole in patients with invasive mold disease (imd): outcomes in patients with pulmonary infections |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781757/ http://dx.doi.org/10.1093/ofid/ofu052.533 |
| work_keys_str_mv | AT raadissam 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT mullanekathleenm 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT selleslagdominik 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT thompsongeorge 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT neofytosdionissios 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT shohamshmuel 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT leemisun 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT maherrochelle 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT zeiherbernhardt 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections AT martyfranciscom 825aphase3randomizeddoubleblindnoninferioritytrialtoevaluateefficacyandsafetyofisavuconazolevsvoriconazoleinpatientswithinvasivemolddiseaseimdoutcomesinpatientswithpulmonaryinfections |